📣 Help Shape the Future of UKRI's Gateway to Research (GtR)

We're improving UKRI's Gateway to Research and are seeking your input! If you would be interested in being interviewed about the improvements we're making and to have your say about how we can make GtR more user-friendly, impactful, and effective for the Research and Innovation community, please email gateway@ukri.org.

Variation in prescribing of lipid-lowering medication in primary care is associated with incidence of cardiovascular disease and all-cause mortality in people with screen-detected diabetes: findings from the ADDITION -Denmark trial (2014)

First Author: Simmons R

Attributed to: Epidemiological contribution to primary and secondary prevention of diabetes and obesity funded by MRC

Abstract

No abstract provided

Bibliographic Information

Digital Object Identifier: http://dx.doi.org/10.1111/dme.12574

PubMed Identifier: 25185778

Publication URI: http://europepmc.org/abstract/MED/25185778

Type: Journal Article/Review

Parent Publication: Diabetic Medicine

Issue: 12

ISSN: 0742-3071